Premium
Estrogens and the lower urinary tract
Author(s) -
Robinson Dudley,
Cardozo Linda
Publication year - 2011
Publication title -
neurourology and urodynamics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 90
eISSN - 1520-6777
pISSN - 0733-2467
DOI - 10.1002/nau.21106
Subject(s) - medicine , genitourinary system , urinary system , overactive bladder , urinary incontinence , menopause , gynecology , atrophy , etiology , urology , physiology , pathology , alternative medicine
The urogenital tract is sensitive to the effect of oestrogen and progesterone throughout adult life. Epidemiological studies have implicated oestrogen deficiency in the aetiology of lower urinary tract symptoms occurring following the menopause. Although to date the role of oestrogen replacement therapy in the management of postmenopausal urinary incontinence remains controversial its use in the management of women complaining of urogenital atrophy is now well established. This aim of this paper is to review the recent evidence regarding the urogenital effects of hormone therapy with a particular emphasis on the management of postmenopausal urinary incontinence, overactive bladder, recurrent lower urinary tract infections and urogenital atrophy. In addition to a review of the available evidence suggestions are also made regarding priorities for further research in the field. Neurourol. Urodynam. 30:754–757, 2011. © 2011 Wiley‐Liss, Inc.